Related Experiment Videos
Clonality in juvenile chronic myelogenous leukemia
L Busque1, D G Gilliland, J T Prchal
1Division of Hematology-Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Blood
|January 1, 1995
Summary
Juvenile chronic myelogenous leukemia (JCML) is a clonal myeloid malignancy. This study demonstrates JCML originates from a single progenitor cell, distinguishing it from reactive conditions and aiding molecular investigations.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Juvenile chronic myelogenous leukemia (JCML) is a rare myeloproliferative neoplasm.
- Morbidity and mortality in JCML stem from organ failure or bone marrow failure.
- Differentiating JCML from reactive conditions is challenging due to similar clinical presentations.
Purpose of the Study:
- To investigate the cellular origin of JCML using clonality assays.
- To determine if JCML arises from a monoclonal or polyclonal process.
- To establish a basis for identifying causative mutations in JCML.
Main Methods:
- Analyzed X-chromosome inactivation patterns in nine female JCML patients.
- Utilized three polymerase chain reaction-based clonality assays.
- Performed cell separation to trace monoclonal origin to primitive myeloid progenitors.
Main Results:
- All nine JCML patients exhibited monoclonal origin of mononuclear cells at diagnosis.
- Monoclonal origin was traced back to primitive myeloid progenitor cells.
- Reversion to a polyclonal state was observed post-bone marrow transplant and with 13-cis retinoic acid treatment.
Conclusions:
- JCML is a clonal myeloid malignancy originating from a single progenitor cell.
- Clonality studies differentiate JCML from reactive myelomonocytic processes.
- These findings support molecular genetic strategies for identifying JCML-associated mutations.